We are live on
!
Find out more
VM
VV Manager Portfolio holdings
AUM
$114M
1-Year Est. Return
59.16%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+59.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$134M
AUM Growth
-$50M
(-27%)
Cap. Flow
-$51.2M
Cap. Flow
% of AUM
-38.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allogene Therapeutics
ALLO
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
MCM
GTP
APG
LM
VPMV
CCM
CCM
BWM
VV Manager's Q3 2019 Portfolio in Review
As of Q3 2019, VV Manager held 3 positions worth $134M, down 27% from $184M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
VV Manager withdrew a net $51.2M in Q3 2019, reducing 1 holding. Its largest reduction was Allogene Therapeutics, cutting an estimated $51.2M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- VV Manager's biggest Q3 2019 reduction was Allogene Therapeutics, cutting an estimated $51.2M.
- VV Manager's ten largest holdings make up 100% of its $134M portfolio in Q3 2019.
- VV Manager opened 0 new positions and closed 0 in Q3 2019.
- VV Manager's portfolio value fell 27% quarter-over-quarter to $134M.
Based on VV Manager's 13F filing for Q3 2019, filed 15 Oct 2019.